1. Home
  2. LUNG vs TSI Comparison

LUNG vs TSI Comparison

Compare LUNG & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • TSI
  • Stock Information
  • Founded
  • LUNG 1995
  • TSI 1987
  • Country
  • LUNG United States
  • TSI United States
  • Employees
  • LUNG N/A
  • TSI N/A
  • Industry
  • LUNG Industrial Specialties
  • TSI Investment Managers
  • Sector
  • LUNG Health Care
  • TSI Finance
  • Exchange
  • LUNG Nasdaq
  • TSI Nasdaq
  • Market Cap
  • LUNG 248.0M
  • TSI 244.7M
  • IPO Year
  • LUNG 2020
  • TSI N/A
  • Fundamental
  • Price
  • LUNG $7.19
  • TSI $5.04
  • Analyst Decision
  • LUNG Strong Buy
  • TSI
  • Analyst Count
  • LUNG 7
  • TSI 0
  • Target Price
  • LUNG $13.71
  • TSI N/A
  • AVG Volume (30 Days)
  • LUNG 240.7K
  • TSI 106.8K
  • Earning Date
  • LUNG 10-28-2024
  • TSI 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • TSI 7.46%
  • EPS Growth
  • LUNG N/A
  • TSI N/A
  • EPS
  • LUNG N/A
  • TSI N/A
  • Revenue
  • LUNG $76,583,000.00
  • TSI N/A
  • Revenue This Year
  • LUNG $22.73
  • TSI N/A
  • Revenue Next Year
  • LUNG $19.02
  • TSI N/A
  • P/E Ratio
  • LUNG N/A
  • TSI N/A
  • Revenue Growth
  • LUNG 26.26
  • TSI N/A
  • 52 Week Low
  • LUNG $5.46
  • TSI $4.48
  • 52 Week High
  • LUNG $14.84
  • TSI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 40.28
  • TSI 42.67
  • Support Level
  • LUNG $7.18
  • TSI $5.02
  • Resistance Level
  • LUNG $7.47
  • TSI $5.10
  • Average True Range (ATR)
  • LUNG 0.37
  • TSI 0.06
  • MACD
  • LUNG -0.17
  • TSI -0.02
  • Stochastic Oscillator
  • LUNG 2.79
  • TSI 15.37

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.

Share on Social Networks: